Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 1,327 other Healthcare companies
Ranked #812 of 1,328 · scores higher than 37% of peers
Bars: peers in each 10-point band of the overall score233 peers with an overall score of 40–49, including AXGN · Click a bar to see the companies
| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 4 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 812 | 1.9B CNY (≈$270M) | 44 | 37 | 4 | 64 | 0 / 2 | |
| 812 | 12.8B CNY (≈$1.8B) | 44 | 46 | 4 | 55 | 0 / 2 | |
| 812 | 1.0B MYR (≈$229M) | 44 | 89 | 20 | 53 | 2 / 2 | |
| 812 | 1.7B USD | 44 | 80 | 22 | 48 | 2 / 2 | |
| 812 | 2.9B USD | 44 | 8 | 65 | 29 | 0 / 2 | |
| 812 | 250M SEK (≈$25M) | 44 | 8 | 92 | 10 | 1 / 2 | |
| 812 | 320M USD | 44 | 79 | 4 | 84 | 2 / 2 | |
| 812 | 3.3B USD | 44 | 8 | — | 26 | 0 / 2 | |
| 812 | 216M USD | 44 | 33 | — | 4 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score